Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JEFFREY M SOBELL

Allopathic & Osteopathic Physicians Dermatology

NPI
1154383610
CMS profile
51651
Location
CHESTNUT HILL, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$84,220.21

117 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 117 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JEFFREY M SOBELL

NPI 1154383610 · CMS profile ID 51651

Allopathic & Osteopathic Physicians / Dermatology

CHESTNUT HILL, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 117 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1154383610?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JEFFREY M SOBELL, NPI 1154383610, CMS profile ID 51651. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 117 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1154383610?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). JEFFREY M SOBELL, NPI 1154383610, CMS profile ID 51651. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 117 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1154383610?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
JEFFREY M SOBELL, NPI 1154383610, CMS profile ID 51651, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 117 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1154383610?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

117 matching records · $84,220.21 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 117 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 117.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $600.0005/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722135833 CMS
AbbVie Inc. $600.0004/20/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722135831 CMS
Janssen Scientific Affairs, LLC $975.0004/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197911 CMS
Novartis Pharmaceuticals Corporation $1,200.0004/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726141643 CMS
AbbVie Inc. $300.0003/18/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722135829 CMS
Lilly USA, LLC $575.0003/18/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728473551 CMS
Janssen Biotech, Inc. $4.3103/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197921 CMS
Janssen Biotech, Inc. $1.5803/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197923 CMS
Novartis Pharmaceuticals Corporation $27.0303/05/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726141631 CMS
Novartis Pharmaceuticals Corporation $3,000.0003/05/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726141635 CMS
Novartis Pharmaceuticals Corporation $68.6303/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726141637 CMS
Novartis Pharmaceuticals Corporation $2.7003/05/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726141641 CMS
Janssen Biotech, Inc. $1.9203/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197881 CMS
Janssen Biotech, Inc. $11.2803/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197883 CMS
Sun Pharmaceutical Industries Inc. $11.2903/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728267965 CMS
Sun Pharmaceutical Industries Inc. $0.6303/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728267967 CMS
Lilly USA, LLC $2,300.0002/28/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728473549 CMS
Lilly USA, LLC $1,150.0002/28/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728480391 CMS
Janssen Biotech, Inc. $1.5802/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197925 CMS
Janssen Biotech, Inc. $4.4602/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197927 CMS
AbbVie Inc. $3,000.0002/25/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722135825 CMS
AbbVie Inc. $32.2002/25/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722135827 CMS
Lilly USA, LLC $66.8302/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728473545 CMS
Lilly USA, LLC $358.1002/25/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728473547 CMS
Lilly USA, LLC $5.3502/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728483753 CMS
Lilly USA, LLC $13.3702/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728490637 CMS
AbbVie Inc. $125.0002/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722135823 CMS
Janssen Biotech, Inc. $13.2302/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197877 CMS
Janssen Biotech, Inc. $1.9202/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197879 CMS
Lilly USA, LLC $24.0202/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728483755 CMS
LEO Pharma Inc. $27.1102/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746690167 CMS
Janssen Biotech, Inc. $1.6202/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197929 CMS
Janssen Biotech, Inc. $4.6902/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197931 CMS
Novartis Pharmaceuticals Corporation $19.4902/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726141647 CMS
Amgen Inc. $31.8402/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741398893 CMS
Janssen Biotech, Inc. $12.0502/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197889 CMS
Janssen Biotech, Inc. $1.9202/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197895 CMS
Janssen Biotech, Inc. $12.3501/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197891 CMS
Janssen Biotech, Inc. $1.9201/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197893 CMS
LEO Pharma Inc. $18.9901/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746690163 CMS
AbbVie Inc. $1,800.0001/27/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722135821 CMS
Amgen Inc. $87.1501/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741398895 CMS
Amgen Inc. $4,050.0001/23/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741398897 CMS
Amgen Inc. $707.2001/23/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741398899 CMS
GENZYME CORPORATION $24.3601/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744152967 CMS
Janssen Biotech, Inc. $1.6201/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197935 CMS
Janssen Biotech, Inc. $4.4701/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197937 CMS
Janssen Scientific Affairs, LLC $975.0001/17/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197903 CMS
Janssen Scientific Affairs, LLC $125.0001/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197905 CMS
Janssen Scientific Affairs, LLC $679.7701/16/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719197907 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $200,427.14 343
PY2020 $84,220.21 117
PY2021 $71,930.98 121
PY2022 $94,217.99 143
PY2023 $209,251.95 288
PY2024 $157,462.69 257
PY2025 $168,026.87 283

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $166,741.82 27
PY2024 Principal investigator $187,687.13 11
PY2023 Principal investigator $36,618.68 8
PY2022 Principal investigator $31,052.60 3
PY2021 Principal investigator $38,060.50 3
PY2020 Recipient $575.00 1
PY2020 Principal investigator $52,526.06 10
PY2019 Recipient $7,197.32 2
PY2019 Principal investigator $107,702.87 15

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

27 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $4,518.00 12/25/2025 Covered Recipient Teaching Hospital
Tufts Medical Center
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Ustekinumab Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1175305476
Principal investigator 1 PFIZER INC. $10,190.49 12/25/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A PHASE 3 EXTERNAL AND SYNTHETIC PLACEBOCONTROLLED RANDOMIZED STUDY WITH DOSEUP FOR NONRESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG AND 100 MG ONCE DAILY IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH ALOPECIA AREATA No dispute reported 06/30/2026 1228749509
Principal investigator 1 PFIZER INC. $2,926.13 12/17/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A PHASE 3 EXTERNAL AND SYNTHETIC PLACEBOCONTROLLED RANDOMIZED STUDY WITH DOSEUP FOR NONRESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG AND 100 MG ONCE DAILY IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH ALOPECIA AREATA No dispute reported 06/30/2026 1228747994
Principal investigator 1 PFIZER INC. $10,190.49 12/11/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A PHASE 3 EXTERNAL AND SYNTHETIC PLACEBOCONTROLLED RANDOMIZED STUDY WITH DOSEUP FOR NONRESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG AND 100 MG ONCE DAILY IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH ALOPECIA AREATA No dispute reported 06/30/2026 1228749184
Principal investigator 1 Janssen Research & Development, LLC $8,597.00 12/01/2025 Covered Recipient Teaching Hospital
Tufts Medical Center
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Ustekinumab Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1175305454
Principal investigator 1 PFIZER INC. $14,528.72 11/26/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A PHASE 3 EXTERNAL AND SYNTHETIC PLACEBOCONTROLLED RANDOMIZED STUDY WITH DOSEUP FOR NONRESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG AND 100 MG ONCE DAILY IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH ALOPECIA AREATA No dispute reported 06/30/2026 1228728015
Principal investigator 1 ABBVIE INC. $1,262.20 11/04/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202423205
Principal investigator 1 ABBVIE INC. $500.00 10/30/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202423201
Principal investigator 1 Janssen Research & Development, LLC $4,518.00 10/24/2025 Covered Recipient Teaching Hospital
Tufts Medical Center
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Ustekinumab Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1175305425
Principal investigator 1 Janssen Research & Development, LLC $27,625.00 10/17/2025 Covered Recipient Teaching Hospital
Tufts Medical Center
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Ustekinumab Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1175305486
Principal investigator 1 Janssen Research & Development, LLC $2,748.00 10/17/2025 Covered Recipient Teaching Hospital
Tufts Medical Center
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Ustekinumab Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1175305550
Principal investigator 1 ABBVIE INC. $1,110.20 10/10/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202423193
Principal investigator 1 Janssen Research & Development, LLC $2,259.00 09/29/2025 Covered Recipient Teaching Hospital
Tufts Medical Center
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Ustekinumab Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1175305409
Principal investigator 1 PFIZER INC. $25,050.00 09/09/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A PHASE 3 EXTERNAL AND SYNTHETIC PLACEBOCONTROLLED RANDOMIZED STUDY WITH DOSEUP FOR NONRESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG AND 100 MG ONCE DAILY IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH ALOPECIA AREATA No dispute reported 06/30/2026 1228761944
Principal investigator 1 Janssen Research & Development, LLC $9,594.00 09/08/2025 Covered Recipient Teaching Hospital
Tufts Medical Center
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Ustekinumab Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1175305508
Principal investigator 1 ABBVIE INC. $1,864.70 09/03/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202423165
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $500.00 08/07/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT PATIENTS WITH BULLOUS PEMPHIGOID No dispute reported 06/30/2026 1184137507
Principal investigator 1 ABBVIE INC. $318.80 08/05/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202423144
Principal investigator 1 Eli Lilly and Company $3,012.00 06/16/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BARICITINIB IN ADULT PATIENTS WITH SEVERE ALOPECIA AREATA No dispute reported 06/30/2026 1187877423
Principal investigator 1 ABBVIE INC. $1,262.20 06/03/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202423121
Principal investigator 1 ABBVIE INC. $1,864.70 05/06/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202423105
Principal investigator 1 ABBVIE INC. $1,262.20 04/03/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202423090
Principal investigator 1 ABBVIE INC. $17,932.20 02/25/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
M16-047 - A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202423062
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $4,540.77 02/14/2025 Covered Recipient Teaching Hospital
Tufts Medical Center
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis (POETYK PSO-LTE) No dispute reported 06/30/2026 1236000090
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $4,121.12 01/17/2025 Non-covered Recipient Entity
Ora
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis (POETYK PSO-LTE) No dispute reported 06/30/2026 1235994844
Principal investigator 1 ABBVIE INC. $3,000.00 01/07/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
M16-047 - A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202423037
Principal investigator 1 ABBVIE INC. $1,445.90 01/02/2025 Covered Recipient Teaching Hospital
TUFTS MEDICAL CENTER
M16-047 - A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202423033